332 related articles for article (PubMed ID: 24493696)
1. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.
Li X; Chen YT; Hu P; Huang WC
Mol Cancer Ther; 2014 Apr; 13(4):855-66. PubMed ID: 24493696
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
3. Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division.
Gholkar AA; Cheung K; Williams KJ; Lo YC; Hamideh SA; Nnebe C; Khuu C; Bensinger SJ; Torres JZ
J Biol Chem; 2016 Aug; 291(33):17001-8. PubMed ID: 27378817
[TBL] [Abstract][Full Text] [Related]
4. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
5. Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma.
Gao S; Shi Z; Li X; Li W; Wang Y; Liu Z; Jiang J
Oncol Rep; 2018 Apr; 39(4):1919-1929. PubMed ID: 29436682
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
7. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
[TBL] [Abstract][Full Text] [Related]
9.
Huang SY; Huang GJ; Wu HC; Kao MC; Huang WC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301150
[TBL] [Abstract][Full Text] [Related]
10. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner.
Shao W; Machamer CE; Espenshade PJ
J Lipid Res; 2016 Aug; 57(8):1564-73. PubMed ID: 27324795
[TBL] [Abstract][Full Text] [Related]
11. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.
Kamisuki S; Mao Q; Abu-Elheiga L; Gu Z; Kugimiya A; Kwon Y; Shinohara T; Kawazoe Y; Sato S; Asakura K; Choo HY; Sakai J; Wakil SJ; Uesugi M
Chem Biol; 2009 Aug; 16(8):882-92. PubMed ID: 19716478
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
13. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.
Huang WC; Li X; Liu J; Lin J; Chung LW
Mol Cancer Res; 2012 Jan; 10(1):133-42. PubMed ID: 22064655
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
[TBL] [Abstract][Full Text] [Related]
15. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
16. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
[TBL] [Abstract][Full Text] [Related]
17. White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft.
Wang X; Ha D; Mori H; Chen S
J Nutr Biochem; 2021 Mar; 89():108580. PubMed ID: 33388344
[TBL] [Abstract][Full Text] [Related]
18. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
19. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
Dondoo TO; Fukumori T; Daizumoto K; Fukawa T; Kohzuki M; Kowada M; Kusuhara Y; Mori H; Nakatsuji H; Takahashi M; Kanayama HO
Anticancer Res; 2017 Jan; 37(1):125-134. PubMed ID: 28011482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
